Bayer Animal Health Announces New Credo® D with DStar™

SHAWNEE, Kan., June 13, 2011 /PRNewswire/ -- Bayer Animal Health is introducing the latest innovation for control of darkling beetles in poultry operations, Credo® D, made with DStar™ adjuvant.

Credo D contains DStar and imidacloprid (a chloronicotinyl insecticide), a formulation developed by Bayer Animal Health for effective control of darkling beetles. Credo D with DStar contains a proprietary adjuvant and offers more control of both larval and adult darkling beetles compared to other imidacloprid products.

"Credo D with DStar is an effective new tool for long grow out poultry operations," said Dr. Doug Ross, Manager of Clinical Development Projects for Bayer Animal Health. "We invested research and development resources into this product because the industry told us there was a real need for a solution to the darkling beetle problem. We're proud to say Credo D with DStar is that solution."

The latest research demonstrates the excellent performance of Credo D with DStar on darkling beetles in long grow out conditions.* In a study at a North Carolina broiler farm, at the conclusion of the 59-day grow out, the number of adult and larval darkling beetles in a house treated with Credo D with DStar were nearly 50 percent less compared to a house treated with Credo® SC Insecticide. In another study at a North Carolina turkey brooder farm, poultry houses treated with Credo D with DStar™ had the lowest average adult beetle count five weeks following treatment.

Darkling beetles have long been a serious problem for the poultry industry — spreading disease, destroying insulation and consuming poultry feed, which ultimately means eating away profits. Credo D® with DStar also serves as a resistance management tool for poultry houses when rotated with Tempo® products.

For more information about Credo D with DStar, call Bayer Animal Health Representative at 1-800-633-3796 or visit www.Bayer-AH.com.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.

With sales of EUR 1,120 million (2010), Bayer's Animal Health business is one of the world's leading manufacturers of veterinary drugs. The division manufactures and markets approximately 100 different veterinary drugs and care products for food-supplying animals and companion animals. U.S. Headquarters for Bayer Animal Health is located in Shawnee, Kansas.  Find more information at www.bayerhealthcare.com.

*Data on file

© Bayer (reg'd), the Bayer Cross (reg'd), Tempo®, Credo®, and DStar are trademarks of Bayer.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

SOURCE Bayer HealthCare

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED